{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T12:46:05Z","timestamp":1793105165967,"version":"4.5.0"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T00:00:00Z","timestamp":1706140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Previous observational studies have provided cumulative data linking gut microbiota to myasthenia gravis (MG). However, the causal link between the two remains unexplored. Hence, the current study was performed to explore the causal link between them.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Mendelian randomization (MR) analysis was conducted using the summary statistics of 211 gut microbiota taxa and the largest genome-wide association studies (GWAS) for MG currently available. The inverse variance-weighted (IVW), MR-Egger, weighted median, and weighted mode methods were employed to ascertain the causal influence. Sensitivity studies utilizing several methodologies were then used to assess the robustness of the findings. Lastly, to evaluate reverse causality, a reverse MR analysis was performed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Seven suggestive causal associations between the gastrointestinal microbiota and MG were identified based on the outcomes of the MR analysis. Specifically, phylum Actinobacteria (OR: 0.602, 95% CI: 0.405\u20130.896, <jats:italic>p<\/jats:italic>\u2009=\u20090.012), class Gammaproteobacteria (OR: 0.587, 95% CI: 0.357\u20130.968, <jats:italic>p<\/jats:italic>\u2009=\u20090.037), and families <jats:italic>Defluviitaleaceae<\/jats:italic> (OR: 0.695, 95% CI: 0.485\u20130.996, <jats:italic>p<\/jats:italic>\u2009=\u20090.047), <jats:italic>Family XIII<\/jats:italic> (OR: 0.614, 95% CI: 0.412\u20130.916, <jats:italic>p<\/jats:italic>\u2009=\u20090.017), and <jats:italic>Peptococcaceae<\/jats:italic> (OR: 0.698, 95% CI: 0.505\u20130.964, <jats:italic>p<\/jats:italic>\u2009=\u20090.029) had suggestive protective effects on MG, while order Mollicutes RF9 (OR: 1.424, 95% CI: 1.015\u20131.998, <jats:italic>p<\/jats:italic>\u2009=\u20090.041) and genus <jats:italic>Faecalibacterium<\/jats:italic> (OR: 1.763, 95% CI: 1.220\u20132.547, <jats:italic>p<\/jats:italic>\u2009=\u20090.003) were suggestive risk factors for MG. The outcomes indicate that neither heterogeneity nor horizontal pleiotropy had any discernible impact. Nevertheless, this reverse analysis did not reveal any apparent effect of MG on the gut microbiota composition.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The MR investigation has substantiated the suggestive causal connection between gut microbiota and MG, which may provide helpful insights for innovative therapeutic and preventative approaches for MG. Further randomized controlled trials are needed to elucidate the gut microbiota\u2019s precise role and therapeutic potential in the pathogenesis of MG.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2024.1309530","type":"journal-article","created":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T04:40:46Z","timestamp":1706157646000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Causal relationship between gut microbiota and myasthenia gravis: a two-sample Mendelian randomization study"],"prefix":"10.3389","volume":"15","author":[{"given":"Chuanhao","family":"Mi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajiao","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianghua","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,1,25]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/s1474-4422(15)00145-3","article-title":"Myasthenia gravis: subgroup classification and therapeutic strategies","volume":"14","author":"Gilhus","year":"2015","journal-title":"Lancet Neurol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41572-019-0079-y","article-title":"Myasthenia gravis","volume":"5","author":"Gilhus","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1097\/wco.0000000000000596","article-title":"Myasthenia gravis: from autoantibodies to therapy","volume":"31","author":"Mantegazza","year":"2018","journal-title":"Curr Opin Neurol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ajo.2019.09.019","article-title":"Factors affecting generalization of ocular myasthenia gravis in patients with positive acetylcholine receptor antibody","volume":"209","author":"Apinyawasisuk","year":"2020","journal-title":"Am J Ophthalmol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"109173","DOI":"10.1016\/j.clim.2022.109173","article-title":"Gut microbiota and metabolites in myasthenia gravis: early diagnostic biomarkers and therapeutic strategies","volume":"245","author":"Kang","year":"2022","journal-title":"Clin Immunol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1097\/wno.0000000000000350","article-title":"Ocular myasthenia gravis: toward a risk of generalization score and sample size calculation for a randomized controlled trial of disease modification","volume":"36","author":"Wong","year":"2016","journal-title":"J Neuroophthalmol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1178831","DOI":"10.3389\/fendo.2023.1178831","article-title":"Causal effects of specific gut microbiota on bone mineral density: a two-sample Mendelian randomization study","volume":"14","author":"Chen","year":"2023","journal-title":"Front Endocrinol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1059281","DOI":"10.3389\/fmicb.2022.1059281","article-title":"Causal associations between gut microbiota and adverse pregnancy outcomes: a two-sample Mendelian randomization study","volume":"13","author":"Li","year":"2022","journal-title":"Front Microbiol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.3389\/fmicb.2018.02627","article-title":"Altered gut microbiota in myasthenia gravis","volume":"9","author":"Qiu","year":"2018","journal-title":"Front Microbiol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"14384","DOI":"10.1038\/s41598-018-32700-y","article-title":"Fecal microbiota profile in a Group of Myasthenia Gravis Patients","volume":"8","author":"Moris","year":"2018","journal-title":"Sci Rep"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12974-016-0475-0","article-title":"Exosomes derived from atorvastatin-modified bone marrow dendritic cells ameliorate experimental autoimmune myasthenia gravis by up-regulated levels of Ido\/Treg and partly dependent on Fasl\/Fas pathway","volume":"13","author":"Li","year":"2016","journal-title":"J Neuroinflammation"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1901441","DOI":"10.1002\/advs.201901441","article-title":"Perturbed microbial ecology in myasthenia gravis: evidence from the gut microbiome and fecal metabolome","volume":"6","author":"Zheng","year":"2019","journal-title":"Adv Sci"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"609765","DOI":"10.3389\/fimmu.2020.609765","article-title":"Ocular microbiota and intraocular inflammation","volume":"11","author":"Li","year":"2020","journal-title":"Front Immunol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1097\/ede.0000000000000699","article-title":"Nature as a Trialist?: deconstructing the analogy between Mendelian randomization and randomized trials","volume":"28","author":"Swanson","year":"2017","journal-title":"Epidemiology"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1177\/0962280215597579","article-title":"A review of instrumental variable estimators for Mendelian randomization","volume":"26","author":"Burgess","year":"2017","journal-title":"Stat Methods Med Res"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.1136\/annrheumdis-2019-216565","article-title":"Non-causal Association of gut Microbiome on the risk of rheumatoid arthritis: a Mendelian randomisation study","volume":"80","author":"Inamo","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"667097","DOI":"10.3389\/fimmu.2021.667097","article-title":"Causal effects of gut microbiome on systemic lupus erythematosus: a two-sample Mendelian randomization study","volume":"12","author":"Xiang","year":"2021","journal-title":"Front Immunol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"746998","DOI":"10.3389\/fimmu.2021.746998","article-title":"Causal relationship between gut microbiota and autoimmune diseases: a two-sample Mendelian randomization study","volume":"12","author":"Xu","year":"2021","journal-title":"Front Immunol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"k601","DOI":"10.1136\/bmj.k601","article-title":"Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians","volume":"362","author":"Davies","year":"2018","journal-title":"BMJ"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1001\/jama.2021.18236","article-title":"Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: the Strobe-Mr statement","volume":"326","author":"Skrivankova","year":"2021","journal-title":"JAMA"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41588-020-00763-1","article-title":"Large-scale association analyses identify host factors influencing human gut microbiome composition","volume":"53","author":"Kurilshikov","year":"2021","journal-title":"Nat Genet"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"e2206754119","DOI":"10.1073\/pnas.2108672119","article-title":"Identification of genetic risk loci and prioritization of genes and pathways for myasthenia gravis: a genome-wide association study","volume":"119","author":"Chia","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1186\/s12916-022-02657-x","article-title":"Association between gut microbiota and preeclampsia-eclampsia: a two-sample Mendelian randomization study","volume":"20","author":"Li","year":"2022","journal-title":"BMC Med"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1093\/eurjpc\/zwad171","article-title":"Causal relationships between the gut microbiome, blood lipids, and heart failure: a Mendelian randomization analysis","volume":"30","author":"Dai","year":"2023","journal-title":"Eur J Prev Cardiol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12916-023-02761-6","article-title":"Causal relationship between gut microbiota and cancers: a two-sample Mendelian randomisation study","volume":"21","author":"Long","year":"2023","journal-title":"BMC Med"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature15393","article-title":"A global reference for human genetic variation","volume":"526","author":"Auton","year":"2015","journal-title":"Nature"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1002\/sim.4197","article-title":"Bias in causal estimates from Mendelian randomization studies with weak instruments","volume":"30","author":"Burgess","year":"2011","journal-title":"Stat Med"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"10","DOI":"10.7554\/eLife.73873","article-title":"Association of Lipid-Lowering Drugs with Covid-19 outcomes from a Mendelian randomization study","volume":"10","author":"Huang","year":"2021","journal-title":"elife"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s10194-023-01609-x","article-title":"A causal effects of gut microbiota in the development of migraine","volume":"24","author":"He","year":"2023","journal-title":"J Headache Pain"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1002\/hep.32183","article-title":"Insights into modifiable risk factors of Cholelithiasis: a mendelian randomization study","volume":"75","author":"Chen","year":"2022","journal-title":"Hepatology"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/gepi.21758","article-title":"Mendelian randomization analysis with multiple genetic variants using summarized data","volume":"37","author":"Burgess","year":"2013","journal-title":"Genet Epidemiol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and Bias detection through Egger regression","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1093\/ije\/dyx102","article-title":"Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption","volume":"46","author":"Hartwig","year":"2017","journal-title":"Int J Epidemiol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1002\/sim.6835","article-title":"Combining information on multiple instrumental variables in Mendelian randomization: comparison of allele score and summarized data methods","volume":"35","author":"Burgess","year":"2016","journal-title":"Stat Med"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2202\/1557-4679.1103","article-title":"Exact calculations of average power for the Benjamini-Hochberg procedure","volume":"4","author":"Glueck","year":"2008","journal-title":"Int J Biostat"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12916-023-02863-1","article-title":"Cross-talks between gut microbiota and tobacco smoking: a two-sample Mendelian randomization study","volume":"21","author":"Fan","year":"2023","journal-title":"BMC Med"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"4851","DOI":"10.1093\/bioinformatics\/btz469","article-title":"Phenoscanner V2: An expanded tool for searching human genotype-phenotype associations","volume":"35","author":"Kamat","year":"2019","journal-title":"Bioinformatics"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12883-017-0857-7","article-title":"Clinical predictors for the prognosis of myasthenia gravis","volume":"17","author":"Wang","year":"2017","journal-title":"BMC Neurol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s00408-021-00444-8","article-title":"The association between asthma and risk of myasthenia gravis: a systematic review and Meta-analysis","volume":"199","author":"Yingchoncharoen","year":"2021","journal-title":"Lung"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1186\/s12883-023-03343-y","article-title":"Genetically predicted effects of physical activity and sedentary behavior on myasthenia gravis: evidence from Mendelian randomization study","volume":"23","author":"Li","year":"2023","journal-title":"BMC Neurol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"10729","DOI":"10.3390\/ijms231810729","article-title":"Gut Dysbiosis and fecal microbiota transplantation in autoimmune diseases","volume":"23","author":"Belvoncikova","year":"2022","journal-title":"Int J Mol Sci"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"103313","DOI":"10.1016\/j.autrev.2023.103313","article-title":"Microbiota Dysbiosis and myasthenia gravis: Do all roads Lead to Rome?","volume":"22","author":"Kapoor","year":"2023","journal-title":"Autoimmun Rev"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.3390\/nu14081647","article-title":"Exploring the gut microbiome in myasthenia gravis","volume":"14","author":"Thye","year":"2022","journal-title":"Nutrients"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nature11234","article-title":"Structure, function and diversity of the healthy human microbiome","volume":"486","year":"2012","journal-title":"Nature"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12916-021-02034-0","article-title":"Metagenome-wide association study of gut microbiome revealed potential microbial marker set for diagnosis of pediatric myasthenia gravis","volume":"19","author":"Liu","year":"2021","journal-title":"BMC Med"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"742719","DOI":"10.3389\/fimmu.2021.742719","article-title":"Driving cars to bars: the winding road to specific regulatory T cells for tolerance","volume":"12","author":"Scott","year":"2021","journal-title":"Front Immunol"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.smim.2013.10.002","article-title":"Peripheral education of the immune system by the colonic microbiota","volume":"25","author":"Kuhn","year":"2013","journal-title":"Semin Immunol"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1038\/nature08530","article-title":"Regulation of inflammatory responses by gut microbiota and chemoattractant receptor Gpr43","volume":"461","author":"Maslowski","year":"2009","journal-title":"Nature"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"e52119","DOI":"10.1371\/journal.pone.0052119","article-title":"Prophylactic effect of probiotics on the development of experimental autoimmune myasthenia gravis","volume":"7","author":"Chae","year":"2012","journal-title":"PLoS One"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.3390\/nu13041349","article-title":"Gardenia Jasminoides ameliorates antibiotic-associated aggravation of Dncb-induced atopic dermatitis by restoring the intestinal microbiome profile","volume":"13","author":"Kim","year":"2021","journal-title":"Nutrients"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"1248336","DOI":"10.3389\/fneur.2023.1248336","article-title":"Altered gut microbiota and metabolites in untreated myasthenia gravis patients","volume":"14","author":"Ding","year":"2023","journal-title":"Front Neurol"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"17562864211035657","DOI":"10.1177\/17562864211035657","article-title":"Gut bacterial microbiota in patients with myasthenia gravis: results from the Mybiom study","volume":"14","author":"Totzeck","year":"2021","journal-title":"Ther Adv Neurol Disord"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"fuad039","DOI":"10.1093\/femsre\/fuad039","article-title":"Faecalibacterium: a bacterial genus with promising human health applications","volume":"47","author":"Mart\u00edn","year":"2023","journal-title":"FEMS Microbiol Rev"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.mib.2013.06.003","article-title":"Faecalibacterium Prausnitzii and human intestinal health","volume":"16","author":"Miquel","year":"2013","journal-title":"Curr Opin Microbiol"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1167\/iovs.64.12.32","article-title":"Causal effects of gut microbiota on age-related macular degeneration: a Mendelian randomization study","volume":"64","author":"Mao","year":"2023","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s13167-023-00332-6","article-title":"Genetically predicted the causal relationship between gut microbiota and infertility: bidirectional Mendelian randomization analysis in the framework of predictive, preventive, and personalized medicine","volume":"14","author":"Xi","year":"2023","journal-title":"EPMA J"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"1255650","DOI":"10.3389\/fmicb.2023.1255650","article-title":"Dissecting the association between gut microbiota and liver Cancer in European and east Asian populations using Mendelian randomization analysis","volume":"14","author":"Jiang","year":"2023","journal-title":"Front Microbiol"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s13578-023-01163-8","article-title":"Causal relationship between gut microbiota and myasthenia gravis: a bidirectional Mendelian randomization study","volume":"13","author":"Su","year":"2023","journal-title":"Cell Biosci"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1309530\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T04:40:48Z","timestamp":1706157648000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1309530\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,25]]},"references-count":60,"alternative-id":["10.3389\/fneur.2024.1309530"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2024.1309530","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,25]]},"article-number":"1309530"}}